IPP Bureau
Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide
By IPP Bureau - April 23, 2026
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
AbbVie bets $1.4B on North Carolina pharma mega-campus
By IPP Bureau - April 23, 2026
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
IMCD appoints Angelique Kruif as Global People Director
By IPP Bureau - April 23, 2026
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
Evonik bets €80 million on biotech expansion to power next-gen pharma growth
By IPP Bureau - April 23, 2026
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Croda unveils next-gen Matrixyl Neolide to redefine long-lasting skincare performance
By IPP Bureau - April 23, 2026
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Medix Biochemica elevates Petra Furu to CEO role
By IPP Bureau - April 23, 2026
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
By IPP Bureau - April 23, 2026
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Motorica India CRE programme enhances clinician training and patient-centric prosthetic care
By IPP Bureau - April 23, 2026
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Crown Bioscience partners with Turbine to accelerate translational oncology research
By IPP Bureau - April 22, 2026
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
By IPP Bureau - April 22, 2026
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
New brain study reveals why alcohol relapse remains a persistent challenge
By IPP Bureau - April 22, 2026
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
HCL Healthcare opens Bengaluru office to deepen enterprise client engagement
By IPP Bureau - April 22, 2026
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
New guardian protein mechanism identified in aggressive skin cancer progression
By IPP Bureau - April 22, 2026
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
ECI taps industry veteran Khalid Raja to drive strategic growth
By IPP Bureau - April 22, 2026
Move comes amid rising regulatory pressures
US FDA okays Merck's new once-daily HIV pill
By IPP Bureau - April 22, 2026
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir

_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals).jpg)













